|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-9-27
|
|
pubmed:abstractText |
to analyze the long-term immunovirological effect and tolerability of a maraviroc-containing antiretroviral therapy in viraemic and pretreated HIV-infected patients with a high prevalence of hepatitis C virus (HCV) coinfection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1873-4251
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
482-6
|
|
pubmed:meshHeading |
pubmed-meshheading:20642436-Adult,
pubmed-meshheading:20642436-Anti-HIV Agents,
pubmed-meshheading:20642436-Anti-Retroviral Agents,
pubmed-meshheading:20642436-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:20642436-CD4 Lymphocyte Count,
pubmed-meshheading:20642436-Cyclohexanes,
pubmed-meshheading:20642436-Female,
pubmed-meshheading:20642436-HIV Infections,
pubmed-meshheading:20642436-HIV Protease Inhibitors,
pubmed-meshheading:20642436-HIV-1,
pubmed-meshheading:20642436-Hepatitis C, Chronic,
pubmed-meshheading:20642436-Humans,
pubmed-meshheading:20642436-Male,
pubmed-meshheading:20642436-Middle Aged,
pubmed-meshheading:20642436-Pyrrolidinones,
pubmed-meshheading:20642436-Retrospective Studies,
pubmed-meshheading:20642436-Spain,
pubmed-meshheading:20642436-Time,
pubmed-meshheading:20642436-Triazoles,
pubmed-meshheading:20642436-Viral Load
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Long-term immunovirogical effect and tolerability of a maraviroc-containing regimen in routine clinical practice.
|
|
pubmed:affiliation |
Biochemistry Department, Virgen del Rocío University Hospital, Biomedicine Institute of Seville, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
